BioSpace News Archive

Hoth to receive equity stake in Isoprene, full license of VNLG 152 for field of Dermatology and royalties from Isoprene for all other fields including Oncology

Samsung Biologics (207940.KS) has appointed Eun Young Yang as vice president of business development for the company’s expanded CDO (contract development organization) business. “Eun is one

MyoKardia, Inc. (Nasdaq: MYOK) today announced results from the dose-ranging MAVERICK-HCM Phase 2 clinical trial of mavacamten for the treatment of non-obstructive hypertrophic cardiomyopathy (HCM).

OpGen, Inc. (Nasdaq: OPGN, “OpGen”), announced today that, following its Special Meeting of Shareholders held March 30, 2020, OpGen shareholders overwhelmingly voted to approve the proposed business combination with Curetis N.V. OpGen reported that 95% of the votes cast were voted to approve the business combination.

Summary Products: Various medications Issue: Increased demand and stockpiling of medications in response to COVID-19. What to do: Do not buy more medication than usual to help ensure that all Canadians continue to have access to the medications they need and to help prevent drug shortages.

Neocis, Inc., the leader and pioneer in robot-assisted dental implant surgery, announced that they had filed for 510 clearance from the U.S. Food and Drug Administration for a new Yomi® edentulous splint.

An artificial intelligence tool accurately predicted which patients newly infected with the COVID-19 virus would go on to develop severe respiratory disease, a new study found.

QT Medical, a MedTech company focusing on cardiac care with personal electrocardiogram (ECG), announced today a limited time offer of $30 per ECG test to skilled nursing facilities (SNFs) and telehealth services.